Pharmyn ApS: Financial statements 2025
CVR: 37133892
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharmyn ApS (CVR 37133892) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity in the 2025 report amounted to DKK 18,662. The solvency ratio was 75.1%.
- Gross Profit
- DKK -12,457
- Profit/Loss
- DKK -12,409
- Equity
- DKK 18,662
- Total Assets
- DKK 24,851
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -12 t. | -12 t. | 19 t. | 0 |
| 2024 | - | 7 t. | 7 t. | 31 t. | 0 |
| 2023 | - | 10 t. | 10 t. | 24 t. | 0 |
| 2022 | - | -20 t. | -20 t. | 14 t. | 0 |
| 2021 | - | 12 t. | 12 t. | 34 t. | 0 |
Official annual report
How creditworthy is Pharmyn ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharmyn ApS has published its annual report for 2024. Gross profit came to DKK 6,544, and the net result was DKK 6,701.
About Pharmyn ApS
Pharmyn ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Henrik Lund Uth. The company is owned by Henrik Lund Uth. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -12,457 and a net result of DKK -12,409 compared with DKK 6,701 the year before. Equity in the 2025 report amounted to DKK 18,662.